Sema4|GeneDx collaborates on new research demonstrating genome and exome sequencing deliver more diagnostic certainty than multi-gene panels
26 oct. 2022 08h00 HE
|
Sema4
STAMFORD, Conn., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, has collaborated on research debunking a commonly held belief that exome and genome sequencing...
$1.2+ Billion Worldwide Direct-To-Consumer Genetic Testing Industry to 2027 - Rising Public Awareness and Consumer Empowerment Will Support Market Growth
20 oct. 2022 08h08 HE
|
Research and Markets
Dublin, Oct. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Direct-To-Consumer Genetic Testing Market By Test Type, By Technology chips, Targeted Analysis, Whole Genome Sequencing, By Sample, By...
Study Demonstrates the Utility of Exome Sequencing for Diagnosing Autism Spectrum Disorders
13 oct. 2022 08h00 HE
|
Sema4
Research from 19,000 patients with Autism Spectrum Disorders found approximately 90% had prior negative tests, likely contributing to a longer time to diagnosis Data will be presented at the Child...
US Genetic Testing Market Size to Hit USD 10.29 Billion by 2027
07 oct. 2022 07h28 HE
|
Fortune Business Insights
Pune, India, Oct. 07, 2022 (GLOBE NEWSWIRE) -- The US Genetic Testing Market size is expected to achievement momentum by reaching USD 10.29 billion by 2027 while exhibiting an impressive CAGR of...
Global Genetic Testing Market Analysis & Forecasts, 2016-2021 & 2022-2031: Predictive, Carrier, Prenatal and Newborn, Diagnostic, Pharmacogenomic, & Nutrigenomic Testing
06 oct. 2022 06h08 HE
|
Research and Markets
Dublin, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The "Genetic Testing Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global genetic testing market is expected to...
Family Cancer History Still a Mystery to Many Women, Myriad Genetics Survey Finds
28 sept. 2022 09h00 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced results from a nationwide survey it conducted...
Global Rare Disease Genetic Testing Market Report 2022: Government & Regulatory Support for Rare Disease Diagnosis to Drive Growth
16 sept. 2022 04h28 HE
|
Research and Markets
Dublin, Sept. 16, 2022 (GLOBE NEWSWIRE) -- The "Rare Disease Genetic Testing Market Size, Share & Trends Analysis Report by Disease Type (Neurological, CVDs), by Specialty (Molecular,...
Florida Cancer Specialists & Research Institute Celebrates Addition of Next-Generation Genomic Testing Capabilities to Advance Precision Oncology Approach to Patient Care
06 sept. 2022 12h26 HE
|
Florida Cancer Specialists & Research Institute
Fort Myers, Fla., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) celebrated the addition of genomic testing capabilities at its Next Generation...
Novo estudo publicado no Clinical Cancer Research Journal destaca o uso do teste EndoPredict para informar o tratamento em pacientes com câncer de mama na pré-menopausa
31 août 2022 08h00 HE
|
Myriad Genetics, Inc.
O teste EndoPredict, da Myriad Genetics, identificou com precisão mulheres na pré-menopausa com câncer de mama ER+, HER2- que poderiam evitar, com segurança, a quimioterapia adjuvante SALT LAKE CITY,...
New Study Published in Clinical Cancer Research Journal Highlights Use of EndoPredict Test to Inform Treatment for Premenopausal Breast Cancer Patients
31 août 2022 08h00 HE
|
Myriad Genetics, Inc.
Myriad Genetics’ EndoPredict test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid adjuvant chemotherapy SALT LAKE CITY, Aug. 31, 2022 (GLOBE NEWSWIRE)...